News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Conference News CRT 2021 LRT Trial Data Bolster Support for TAVI in Bicuspid Valves L.A. McKeown March 11, 2021
News Conference News CRT 2021 DOAC Use Increasing in Patients With Bioprosthetic Heart Valves Todd Neale March 08, 2021
News Daily News TAVR Yields Similar Success in Failed TAVR or Surgical Valves Caitlin E. Cox January 07, 2021
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Conference News TVT 2020 Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear Todd Neale June 25, 2020
News Conference News TVT 2020 Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events Michael O'Riordan June 23, 2020